PARIS--Genset here announced that it has completely sequenced the genomes of two pathogens, Chlamydia pneumoniae, a possible agent for atherosclerosis lesions, and the Chlamydia trachomatis L2 strain. The company said it is applying for patents for both sequences and that it will license out the therapeutic, diagnostic, and vaccine applications of the genomic data to pharmaceutical companies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.